These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2774968)

  • 41. Safety, pharmacokinetics and efficacy of once-a-day netilmicin and amikacin versus their conventional schedules in patients suffering from pelvic inflammatory disease.
    Ibrahim S; Derde MP; Kaufman L; Clerckx-Braun F; Jacqmin P; Brulein V; Donnez J; Tulkens PM
    Ren Fail; 1990; 12(3):199-203. PubMed ID: 2287773
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Single dose of netilmicin in urinary tract infection.
    Prát V; Horcicková M; Hatala M; Matousovic K; Milotová Z
    J Chemother; 1989 Jul; 1(4 Suppl):865-6. PubMed ID: 16312676
    [No Abstract]   [Full Text] [Related]  

  • 43. Antimicrobial activity of netilmicin in comparison with gentamicin, sisomicin, tobramycin, and amikacin and their resistance patterns.
    Braveny I; Voeckl J; Machka K
    Arzneimittelforschung; 1980; 30(3):491-5. PubMed ID: 7387761
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Netilmicin in the treatment of severe or complicated urinary tract infections.
    Peddie BA; Bailey RR; Blake E; Summerfield MJ
    N Z Med J; 1980 May; 91(660):378-81. PubMed ID: 6931321
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of netilmicin with cefoperazone for the treatment of severe or complicated urinary tract infections.
    Bailey RR; Peddie BA; Lynn KL; Swainson CP
    Aust N Z J Med; 1985 Feb; 15(1):22-6. PubMed ID: 3890818
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The effect of netilmicin, amikacin, ceftazidime and cefotaxime on the adhesive properties of microorganisms isolated from newborn infants].
    Kushnareva MV
    Antibiot Khimioter; 2000; 45(7):17-21. PubMed ID: 10987103
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Netilmicin prevention and therapy in cystoscopic practice].
    Cirillo-Marucco E; Pagliarulo A; Giocoli-Nacci G; Marchesi E
    G Ital Chemioter; 1985; 32(2):481-4. PubMed ID: 3833590
    [No Abstract]   [Full Text] [Related]  

  • 48. Treatment of complicated urinary tract infection caused by Pseudomonas aeruginosa--a comparison of the efficacy of ceftazidime with that of netilmicin.
    Graninger W; Ho I; Francesconi M; Schmidbauer C; Egger T
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():323-4. PubMed ID: 19803008
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Treatment of urinary-tract infections with netilmicin (author's transl)].
    Weissbach L; Prehn U; Krasemann C; Gillissen J; Mette U
    Dtsch Med Wochenschr; 1978 Dec; 103(49):1961-5. PubMed ID: 720228
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative in vitro studies with netilmicin, amikacin, gentamicin, sissomicin and tobramycin.
    Habwe V; Shadomy S
    J Antimicrob Chemother; 1979 Jan; 5(1):73-9. PubMed ID: 762007
    [No Abstract]   [Full Text] [Related]  

  • 51. Trometamol salt of fosfomycin versus netilmicin: randomized multicenter study in children's lower urinary tract infections.
    Varese LA
    Eur Urol; 1987; 13 Suppl 1():119-21. PubMed ID: 3552696
    [No Abstract]   [Full Text] [Related]  

  • 52. [Bolus doses of netilmicin in the treatment of infections of the urinary tract].
    Varese LA; Grazioli F; Antoniola P; Vighetti A; Porcellini G
    G Ital Chemioter; 1985; 32(2):473-6. PubMed ID: 3833588
    [No Abstract]   [Full Text] [Related]  

  • 53. Comparison of multiple-dose regimens of netilmicin in patients with urinary tract infections.
    Cox CE
    J Int Med Res; 1979; 7(5):370-4. PubMed ID: 499645
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Compiled data on aminoglycoside, foremost netilmicin susceptibility of bacterial strains.
    Juhlin I; Tunevall G
    Scand J Infect Dis Suppl; 1980; Suppl 23():39-44. PubMed ID: 6782657
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enzymuria in aminoglycoside-induced kidney damage. Comparative study of gentamicin, amikacin, sisomicin and netilmicin.
    Palla R; Marchitiello M; Tuoni M; Cirami C; Giovannini L; Bertelli AA; Bertelli A
    Int J Clin Pharmacol Res; 1985; 5(5):351-5. PubMed ID: 2866167
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vitro activity of netilmicin against clinical isolates of methicillin resistant and susceptible Staphylococcus aureus.
    Manoharan A; Lalitha MK; Jesudason MV
    Natl Med J India; 1997; 10(2):61-2. PubMed ID: 9153980
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Netilmicin in comparison with tobramycin in the therapy of severe infections in nephropathic patients].
    Chiarini C; Marchesi E; Rigotti A; Spongano M; Galleri C
    Minerva Urol Nefrol; 1985; 37(1):29-33. PubMed ID: 4049190
    [No Abstract]   [Full Text] [Related]  

  • 58. Gentamicin in 1978.
    Appel GB; Neu HC
    Ann Intern Med; 1978 Oct; 89(4):528-38. PubMed ID: 358884
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes in resistance to aminoglycoside antibiotics of different bacterial strains isolated during the period 1978 to 1983. Netilmicin as alternative therapy.
    Bovelacci A; Montini G; Ramacciotti PG
    Chemioterapia; 1985 Dec; 4(6):439-44. PubMed ID: 3830413
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Comparison of the in vitro activity of amikacin, netilmicin, piperacillin and moxalactam against Acinetobacter calcoaceticus var. anitratum].
    Gamazo C; Urra E; Apraiz D; Angel Montañés M
    Med Clin (Barc); 1985 Nov; 85(16):659-60. PubMed ID: 4079560
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.